IDH2 and oligodendroglioma: Clinically, the presence of an IDH mutation is prognostic, and should prompt further classification according to presence of 1p/19q codeletion (diagnostic of oligodendroglioma) and ATRX staining (with loss of staining diagnostic of astrocytic lineage).